Meet Our Team

Mr. Levie has been a guest lecturer at the Harvard Business School, the University of Chicago Graduate School of Business, the Association for Corporate Growth, and the Turnaround Management Association. In addition, he served as a panelist with the Hon. Fabius Laurent, former Prime Minister of France, on Investing in France, at the Consulate General of France in New York City, October 1, 2015. He is the Director Forest Products Association of Canada, Fellow of the Royal Geographical Society, and Member of the Alexander Graham Bell Legacy Society of the National Geographic Society.

Mr. Levie is also a member of the Trilateral Commission, the Bretton Woods Committee, the Council on Foreign Relations Legacy Society, the Economic Club of New York, the Yale CEO Summit, the Chairman’s Legacy Society of the Atlantic Council, the COVID-19 Advisory Board for the Citizens Committee for New York City, the Explorers Club, the Army Navy Club of Washington D.C., the East India Club of London, the Rand Club of Johannesburg, and the Harvard Faculty Club.

In addition, Mr. Levie is a member of the Harvard Business School Clubs of New York, Silicon Valley, London, France, Germany, Spain, the Netherlands, Sweden, Japan, India, Singapore, and South Africa, the Copper Club, the Family Office Association, the Association for Corporate Growth, the Turnaround Management Association, the National Association of Corporate Directors, Chatham House – the Royal Institute of International Affairs, the Policy Exchange, the Japan Society, the Asia Society, Alliance Francaise, the Italy-America Chamber of Commerce, the Goethe Institute, the Canadian International Council, the Americas Society/Council of the Americas, the American Red Cross Legacy Society, the William Society of the Metropolitan Museum of Art, and the Masterpiece Society of the Louvre Museum.

Mr. Levie was awarded the Turnaround Management Association’s 2017, 2018, and 2019 Turnaround of the Year Awards for the revival of Vermont Aerospace Industries, Canadian Kraft Paper Industries, and Union Metal Industries.

In 2013, He joined AIAC, the Industrial holding company owned by Leonard M Levie, AVARA chairman, and since leads acquisition, turnaround, and divestment of several large worldwide AIAC projects, including management team coaching, growth plan deployment, digitalization, design and follow up of restructuring and growth programs. He is director of AVARA since 2016.

As Group Director, Mr. Talabart, alongside the Chairman defines the strategic objectives and work together with the company leadership team to ensure proper alignment and execution of this plan. He also works closely with EVP on specific projects.

Mr. Talabart holds a Master of Science in Mechanical Engineering from the French Institute for Mechanical Engineering and a Master of Business Administration from the Hautes Etudes Commerciales School Paris (HEC Paris). He also gave lecture at INSEAD Singapore and HEC about industrial methodologies and business restructuring. Besides his role at Avara, Mr. Talabart is also director of Neotiss, Bright Green Plastics and Epalia.

He is the Executive Director of the ACA and Rebirth Technology Companies in Japan and previously served as General Manager of Sales at the Suga Test Instrument Company. His long tenure at Sony, Inc. and its subsidiaries includes multiple management and executive positions in Japan, Europe, and the U.S., and he made significant contributions to Sony’s overall growth in the areas of broadcasting and video communications over the past 25 years.

In the U.S., Mr. Nishiwada was the Senior General Manager of B2B Development at Sony’s Business and Professional Division, where he developed successful alliances with U.S. and European industry leaders and established Sony’s Business Solutions unit. Prior to this position, he was the Senior Vice President of Sales and Marketing at the U.S. division of Sony Electronics, overseeing key joint ventures with Panavision and Accenture and increasing profits by $50 million.

In Europe, Mr. Nishiwada served as General Manager of Sony Communications, B.V., in the Netherlands, where he established the company’s B2B operations and tripled the unit’s sales over a five-year period. He has also served as Chairman of the Boards of Corporate Auditors at Felicia Networks, Sony Global Solutions, Sony Marketing and Sony EMCS.

Mr. Nishiwada holds a Master of Management Science and Business Administration degree from Waseda University.

In 1976, Mr. Grebow moved to Morgan’s Profitability Systems Development Group as an Assistant Vice President and developed an account profitability system that was recognized as a model for the banking industry. Mr. Grebow became Vice President and COO of Morgan Bank (Delaware) in 1980, and in 1981 was named Chairman of Morgan Data Services, Inc. In 1982, as Vice President of Strategic Planning and Subsidiary Operations for J.P. Morgan & Company, Inc., Mr. Grebow evaluated acquisitions, advised senior management on expansion and served as a liaison with the Federal Reserve Bank. In 1985, Mr. Grebow was named Executive Vice President and COO of the Bowery Savings Bank. In this role, he worked with investors including Richard Ravitch, Warren Buffet and Laurence Tisch to develop an acquisition plan for the troubled bank. He oversaw operations and implemented cost saving measures that returned the bank to profitability. In 1988, Bowery was sold to H.F. Ahmanson & Co. for $200 million, doubling initial investments in the bank.

Well-known as a versatile problem solver by 1988, Mr. Grebow was named Executive Vice President of CBS Inc., where he was responsible for all operational and administrative functions at the $4 billion broadcast network and reported directly to President and CEO Laurence Tisch. Mr. Grebow managed a work force of 3,400, many of whom were union members, and his work for CBS in the field of labor relations was seen as groundbreaking in the broadcast industry. He oversaw a 40% expansion of CBS’s studio facilities in a seven-year period, and was a pioneer in implementing digital technology in the industry, winning an Engineering Emmy Award for achievement in television technology in 1992.

As part of the team that brought David Letterman to CBS, Mr. Grebow negotiated the purchase and renovation of the historic Ed Sullivan Theater as a home for Late Show with David Letterman. Purchased for $4 million, initial work at the building revealed challenges that many industry insiders doubted he could overcome. The project was, however, completed in 12 weeks—record speed for a project of its kind—and hailed as “The Most Ingenious Deal of 1993” by the Real Estate Board of New York. Upon completion, the CBS-owned theater and adjacent building boasted state-of-the art production and office spaces that also became home to the New York City Mayor’s Office of Film, Theater and Broadcasting.

In 1995, Mr. Grebow was named President of Tele-TV systems, a joint venture between three regional telephone companies that were attempting to develop interactive television services. During his tenure at Tele-TV, Mr. Grebow testified before the Federal Communications Commission on issues surrounding advanced television systems and the allotment of spectrum for digital television broadcasting. Following this position, in 1997, Mr. Grebow became television production equipment maker Chyron Corporation’s President and CEO, seeing this entity through a period of prosperity.

Beginning in 1999, Mr. Grebow led Sony Broadcast and Professional Company through the broadcasting industry’s transition from traditional to digital technology. As President of the leading television equipment manufacturer in the U.S. market, Mr. Grebow oversaw Sony’s partnership with Panavision Inc. to supply filmmakers with high-quality cameras and lenses that significantly advanced digital technology and were embraced by leading filmmakers around the world. He also broadened the company’s client base beyond the broadcasting and filmmaking industries to corporations and internet companies that had begun using digital video technology to meet a variety of needs.

After the tragedy of September 11, 2001, Mr. Grebow stepped down from his role at Sony when he was asked to head the Metropolitan Television Alliance, the organization of New York City broadcasters that was responsible for replacing the broadcast and emergency services transmission facilities that were destroyed in the attack on the World Trade Center. In this role, Mr. Grebow worked to organize alternative means of broadcasting, while a permanent site for a new tower was found and constructed. After consideration of locations in New Jersey and on Governors Island in New York Harbor, Mr. Grebow signed an agreement in 2003 to install 22 analog and digital antennas on the new Freedom Tower at the World Trade Center site.

In 2003, Mr. Grebow joined Ullico, a Washington, DC-based labor union-affiliated financial services and insurance company, as President. Dealing with fallout from several years of financial abuses and criminal activity by former executives and directors, he organized an infusion of capital, sold the company’s headquarters, and led a management overhaul that restored the company’s financial strength and reputation in a short time. His work earned him a reputation as a “turnaround specialist for financial services and labor-focused companies.”¹

Following this success, Mr. Grebow joined the private equity firm J.C. Flowers as a Managing Director in 2007 and oversaw a transaction to privatize student loan giant Sallie Mae. Sallie Mae had lost its government subsidies and was under investigation for aggressive lending practices, and Mr. Grebow’s problem solving acumen and relationships in Washington were to be key parts of the lender’s transition to private ownership. The $25 billion deal would have been the largest ever of its kind in the financial services industry, but the transaction was aborted during the financial crisis of 2008. Union-owned Amalgamated Bank was suffering from deficits that resulted from failed real estate loans and was under threat of closure by the FDIC when Mr. Grebow was hired as President and CEO in 2011.

In just a few months, he raised $100 million in capital for the bank from billionaire investors Wilbur Ross and Ron Burkle. He also oversaw the implementation of a new residential mortgage operation and other innovative retail banking products. Following the reelection of President Barak Obama in 2012, Mr. Grebow developed and implemented strategies to take advantage of the bank’s labor union affiliations so that it would become the bank of the progressive movement in the United States. Amalgamated became the official bank of the Occupy Wall Street movement, and was the only bank to offer financial assistance to the city of Scranton, Pennsylvania, when it was unable to pay its employees their salaries in 2012.

Under Mr. Grebow’s leadership, Amalgamated became the bank for the Democratic National Committee, the Democratic National Convention of 2012 and President Obama’s second inauguration in 2013. On several occasions throughout Mr. Grebow’s tenure, Amalgamated brought derivative lawsuits against corporations on behalf of its many pension fund clients, securing its reputation as a bank that would stand against corporate wrongdoing. These initiatives brought significant business to the bank and were integral to its return to profitability.

With Amalgamated Bank’s stability restored in 2013, Mr. Grebow returned to investment banking as Managing Director of TriArtisan Capital Advisors, where he continues to use his extensive knowledge and expertise in mergers, acquisitions, and financing. He is frequently called upon to serve as interim CEO in troubled situations. In March 2016, he was elected Director of Alcentra Capital Corporation, where he also serves as Chairman and Chairman of the Audit Committee and as a member of the Compensation and Nominating and Corporate Governance Committees. He is Lead Director and Chairman of the Audit Committee at Diamond Offshore Drilling Inc., and is a Director of College Avenue Student Loans Inc.

Mr. Grebow is a trustee of WNET, New York City’s public television station, and of the Laborers International Union Charitable Foundation. He is a former member of the New York State Hospital Review and Planning Council, for which he was nominated by Governor Mario Cuomo and confirmed by the New York State Senate. From 1993 to 2002, he served as a Trustee of George Washington University, where he was also Chairman of the Committee on Academic Affairs. Mr. Grebow’s other former board memberships include the International Association of Fire Fighters Foundation, the American Film Institute, the Theatre Development Fund,  Xenith Bankshares Inc and Panavision Inc. He is a 2013 recipient of the Emerald Isle Society’s Briscoe Award for supporting collaboration between New York City’s Irish-American and Jewish communities.  Born in Lakewood, New Jersey, Mr. Grebow holds a BBA degree in finance and accounting from George Washington University. He currently lives in New York City with his wife and daughter.

National Trust LLC's extensive US real estate holdings serve prominent governmental and corporate tenants, including the US Veterans Affairs Healthcare System, Walmart, Home Depot, Lowes, Stop & Shop Supermarkets, Shaw's Supermarkets, and Cabela's. In the 1990's Mr. Leach pioneered the remediation and development of large, environmentally-challenged real estate with the cooperation of the US Environmental Protection Agency. This public/private process became a model for projects throughout the country. Mr. Leach is a member of the Board of Directors of Kenney Manufacturing Company, a Warwick, RI manufacturer of houseware products established in 1914. 

Mr. Leach is the Chairman of the Rhode Island Public Broadcasting Service (PBS) Foundation, and a former Chairman of the Providence City Planning Commission, where he served for twenty years. He has served as a member of the Board of Trustees of the Lifespan/Miriam Hospital, a 247-bed teaching hospital affiliated with Brown University Medical School and of the Providence Public Library. He has also served as the Vice Chairman of the Touro Synagogue Foundation in Newport, Rhode Island, which preserves this National Historic Site. For his civic and philanthropic contributions, in 2021 Mr. Leach was awarded as Inductee to the Rhode Island Heritage Hall of Fame. 

He is a member of the Board of Trustees and the Treasurer of the Rectory School in Pomfret, CT. Mr. Leach is a member of the Army Navy Club of Washington, D.C., the University Club of Providence, the University Club at Penn, the London Press Club, the Hyannis Yacht Club, and the Family Office Association. 

Mr. Leach is an alumnus of Nasson College and of postgraduate programs in Audit Committee Management and in Nonprofit Organization Management at Harvard Business School, and in Innovation Leadership at the Georgia Institute of Technology. Mr. Leach has been awarded Six Sigma Black Belt certification. 

As Executive Vice President and Hospital Director of New York-Presbyterian Hospital for seven years, Dr. Berman led the integration efforts that enabled the merger of Columbia-Presbyterian and New York Hospital - Cornell Medical Center.

Prior, Dr. Berman served as Professor and Chairman of Pediatrics at the University of Maryland and established its Division of Pediatric Cardiology; he also created Maryland’s Hospital for Children. He was also President of the UM Faculty Practice Foundation and President of UM’s Self-Insurance Program for Hospital & Physicians.

In his early career, he was Director of the Pediatric Catheterization Laboratory at Yale University where he invented the Berman Balloon Angiographic Catheter, known as the standard catheter for infants and children’s heart catheterizations worldwide.

He is currently a Senior Advisor for Lucania Partners and has consulted for Berkeley Research Group (Vanderbilt University), McKinsey & Company (nationally and internationally), Huron, Johnson & Johnson, GE, Phillips Medical, Visicu, and others. Dr. Berman was a member of the Board of Directors of Cadence Pharmaceuticals, playing an instrumental role in bringing it public.

Dr. Berman was also a Personal Consultant for the Dean of the USC Keck School of Medicine and the Dean of the Yale School of Medicine; he was interim CEO of the Yale Medical Group (Faculty Practice Group of Yale School of Medicine), charged with transforming the 19 separate departments into one centralized faculty group practice.

Dr. Berman holds an M.D. from the State University of New York, Syracuse, and completed an internship in the Department of Pediatrics at Johns Hopkins Hospital followed by 2 years at the National Institute of Health’s Heart, Lung and Blood Institution as their Pediatric Cardiologist.

He has published and lectured extensively on Pediatrics, Pediatric Cardiology, and Hospital & Physician Management, Efficiency & Strategy issues. Dr. Berman is recognized as an expert on formal and informal mentoring for executives, corporations, and students. Creative and strategic thinking; leadership; growing organizations; thriving during change and a demonstrated commitment to sound business practices have characterized Dr. Berman’s career.

Dr. van Hoek previously taught at the Cranfield University School of Management in the UK, the largest SCM masters program in Europe, The Erasmus University in Rotterdam, the Netherlands and the Vlerick School of Management in Ghent, Belgium, simultaneously. He has lectured and delivered keynote addresses at conferences around the world, including in Singapore, Finland, Poland, Manchester, Copenhagen, London and Shanghai. He is a fellow of the Chartered Institute of Procurement and Supply and the Chartered Institute of Logistics and Transportation, in the UK, and holds a fellowship at the Dole Institute at the University of Kansas, USA. Dr. Van Hoek served on CILT international committees and as Chairman of the Board of Directors of CSCMP. He has been on the CSMCP Board of Directors for over a decade and continues to serve on the Supply Chain Hall of Fame committee.

Dr. van Hoek is a co-author of three authoritative textbooks on supply chain management: Leading Procurement Strategy: Driving Value Through the Supply Chain (now in its 3rd edition); Integrating Blockchain into Supply Chain Management: A Toolkit for Practical Implementation; and Logistics Management and Strategy: Competing Through the Supply Chain (now in its 6th edition and translated into 7 languages and listed in the top 7 supply chain books of all times). He has authored 100+ articles that have been cited almost 9,000 times, winning him several best paper awards and placing him in the top 2% business scholars around the world in a Stanford/Elsevier study, October 2021. He has published an editor’s pick article about blockchain in the Spring 2021 issue of the Sloan Management Review and has published in the Harvard Business Review over a two-decade period, including his recent work on the COVID19 and blockchain. He is the only researcher to win the Plowman best paper award from CSCMP 3 times during his career, across a 3 decade period, and he was the first non-US CSCMP best doctoral dissertation award winner. In 2021 he won the IPSERA best paper award with managerial implications for his work on navigating the pandemic effect in the supply chain.

While a visiting professor at the Cranfield University School of Management, Dr. van Hoek served in senior supply chain and procurement leadership roles in Europe and the US with Walt Disney Corporation (global CPO reporting to the group CFO), Nike, Inc., and PwC (reporting to the vice-chairman of the firm in New York, serving major corporates including GSK and Pfizer). He also built and ran the procurement and supply chain practices of CEB (now Gartner, Inc.), serving CPO’s and CSCO’s of major corporates including GSK, Novartis, Pfizer, Merck, and Astra Zeneca.

Dr. van Hoek is currently an executive and board advisor to several companies, including on procurement for the CFO of Webhelp a BPO based in Paris, France. Other organizations that he advises include Moet Hennessey (CFO and CPO) and Baker McKenzie. He has also been supporting American manufacturers of medium and small size navigate the pandemic supply chain environment with a focus on near and local sourcing, supply base diversification and collaboration with American contract manufacturers. In 2020 Dr. van Hoek was named Supply Chain Rainmaker by DC Quarterly. 

Ms. Chandonnet’s 17 years of in-house counsel experience was primarily in the pharmaceutical / life sciences / healthcare industry, most recently as the Head of US Legal Operations at Sanofi & Aventis Pharmaceuticals. She has provided legal support for licensing, M&A, business development, procurement, manufacture and supply agreements, commercial contracts and corporate governance. She also worked with drafting policies, venture capital investments agreements, alliance management, securities, and real estate matters. She has experience with advising on commercialized product brand support.

At Morgan Lewis & Bockius and at K&L Gates, Ms. Chandonnet advised corporate clients in contracts, financing, securities transactions, and other strategic matters. Her clients included a variety of clients including large pharmaceutical companies as well as smaller, emerging biotech and life sciences companies.

Ms. Chandonnet also has an extensive finance background, having served as a treasury and operations executive in the telecommunications industry.

She holds a BS from Penn State University, an MBA from the University of Delaware, and a JD from Rutgers University School of Law. Ms. Chandonnet is admitted as a lawyer in New Jersey, Pennsylvania and North Carolina.

Yolanda has over 20 years of scientific and management experience in numerous public and private companies. She is advising clients across USA, Europe, Latin America, Middle East, and Asia. Her engagement focuses on research and development, operational strategy and change management, emerging markets’ expansion focused on new technology trends within pharmaceutical and biotechnology, and market access. Yolanda has long-standing expertise in leading and developing the project management operations function in the pharmaceutical and biotech space. She has built a reputation for agile operational excellence, driving innovative, strategy, working with the highest level of integrity, and a deep and passionate commitment to CiNTL clients.

Yolanda founded C. International while a student at Yale School of Medicine and spearheaded the design and development of a clinical database which led to additional client collaborations and expanding her consulting firm in the Netherlands where she would later partner up to form CiNTL.

Yolanda has held various senior management positions in the pharmaceutical and biotechnology industry. From negotiating RFPs to being a liaison between pharmaceutical companies and government public health officials.

Prior to working at CiNTL, Yolanda held leadership roles for Astellas Pharmaceutical, Genzyme, and PRA International, leading project managers and directors and supervising global Phase 1-IV portfolios and was a key contributor to the EMA and FDA approval of Myozyme® for the treatment of Pompe disease. In her roles, Yolanda has been responsible for projects with operating budgets of $500 million and has played a key role in improving and scaling up the procurement of projects by 30% in one year.

She serves on several boards, she is on the board of American Industrial Acquisition Corporation as a Senior Advisor, on the Board of Directors for The Project Management Institute as VP and has served as the chairman of The Hera International Foundation. She has given speeches in conferences and in 2021 founded LeadingLatinx, a platform that highlights stories of Latinx Leaders making social impact and covering topics related to Diversity and Inclusion of women on boards.

Yolanda has won several scientific awards, including receiving a NIH Forgarty International Research Grant and has been recognized in WHO’s Who In Medicine and Research. In addition, she has co-published in multiple Scientific Journals and recently published a book on Access to Medicines.
In October 2021, Yolanda was selected as member of Topvrouw (TopWoman) for the Netherlands.

Yolanda holds a Master of Public Health (MPH) from Vrije University (VU), The Netherlands and did her medical school education at Yale School of Medicine in New Haven, Connecticut.

Yolanda is fluent in Spanish and English and is proficient in Dutch.

A retired U.S. Marine Corps officer, Roger served for more than two decades in both command and staff positions, including multiple combat tours in Iraq. His career is distinguished by service in the White House Military Office during the George W. Bush administration, and by his later selection for a Marine Corps Fellowship at the Johns Hopkins University School of Advanced International Studies. Roger’s decorations include the Bronze Star, Defense Meritorious Service Medals, Navy and Marine Corps Commendation Medal, and the NATO Medal among others.

Upon completion of his military service, Roger spent several years in the private sector where he served as an executive at CACI Inc., responsible for business development and strategic growth of a information technology portfolio. He consistently produced results, annually delivering on-contract and emerging opportunity growth in his market segment over a multi-year period. Additional private sector positions included Strategic Risk Management Consultant at AKIMA, and an Executive Management Consultant at the Patuxent Partnership, LLC where he provided specialized technical services to Department of Defense acquisitions officials for classified command and control systems.

Having achieved success in the private sector, Roger accepted an appointment as the Assistant Administrator for Continuity Operations at the Federal Emergency Management Agency (FEMA) during the Obama Administration. He was responsible for coordinating risk management, continuity, and disaster recovery operations for federal departments and agencies, and directed the National Response Coordination Center, where he coordinated the federal response to 78 federally declared disasters.

Roger later served in the National Security Council as the Senior Director for Resilience, where he advised the National Security and Homeland Security Advisors and developed White House policy in the areas of cybersecurity, critical infrastructure protection, and homeland security.

Roger was appointed Deputy Assistant to the President, and Director of White House Information Technology and was responsible for oversight and direction of all aspects of the information technology enterprise supporting the President, the Vice President, and the White House staff.

In addition to practicing general internal medicine, Dr. Chustecki's work has included educational activities and broad clinical research on a wide range of topics. Dr. Chustecki founded Internal Medicine of Greater New Haven in 2003. As the Managing Director of this organization, she is responsible for medical management, quality control, cost initiatives and an operating budget for a medical group currently serving 24,000 members. She also completed Yale School of Management’s MBA program in 2009. This aided her in creating and leading a medical group and in organizing a medical management team to improve efficiency, performance and communication with patients and the public. She implemented a quality program that achieved NCQA accreditation in eligible markets, and also supported a quality infrastructure for additional programs, such as Meaningful Use and PQRS. In addition, she maintains a clinical practice within the group, resulting in a “hands on” experience with changes being made to the operations. She coordinates medical management to support medical education, using data to improve outcomes, manage costs and improve the quality of healthcare.

As founder and Managing Director of AORF, Dr. Chustecki leveraged her passion for advocating for the welfare of vulnerable children to create a rapidly growing 501(c)(3) that provides medial, personal, and nutritional supplies to orphans and other vulnerable children. Through working with reliable partner organizations in Africa, Eastern Europe, and the US, AORF helps prevent and treat childhood malnutrition, and make life saving-immunizations and treatments accessible to children.

In addition to the Avara Board of Advisors, Dr. Chustecki also serves on the advisory boards of Titanium Fabrication Holding Company, Consolidated Industries, and Integrated Medical Systems. She is a member of the American Medical Association, the Massachusetts Medical Society, the Washington State Medical Association, the Beton-Franklin Medical Society, the New Haven County Medical Association, the Connecticut State Medical Society, and the National Association of Corporate Directors.

A board-certified internist, Dr. Chustecki, studied medicine in Poland and received her MD from the Medical School of Warsaw, Warsaw, Poland. She received her MBA from Yale School of Management.

Dr. Blander studies various aspects of innate immunity and inflammation and their application to human disease. Her laboratory has made important contributions to understanding the innate immune response to microorganisms and dying cells in the context of enteric infections, intestinal homeostasis, and vaccination. Dr. Blander’s achievements include mechanistic dissection of the regulation of the cell biology of antigen presentation and its application to designing vaccines for infectious disease and cancer, the immune consequences of cell death and its translation into new therapies for inflammatory bowel disease, the exploitation of innate immunity, particularly the inflammasome for cancer immunotherapy, and the discovery of vita-PAMPs, signatures of microbial viability and their exploitation for creating safe and effective vaccines.

Dr. Blander’s laboratory was established in 2006 with the appointment of Dr. Blander as Assistant Professor at the Icahn School of Medicine at Mount Sinai. Dr. Blander’s promotion to Associate Professor with tenure in 2011 was followed five years later by an appointment as full professor with tenure at Weill Cornell Medicine-Cornell University in 2016.

Dr. Blander is a member of the Sandra and Edward Meyer Cancer Center at WCM. She is a member of the Executive Committee for the Cornell Center for Immunology, member of the WCM Promotion and Appointment Review Committee, Associate Co-Director of US National Institutes of Health (NIH) T32 training grant to the Department of Medicine Division of Gastroenterology and Hepatology, member of the Senior Research Awards Committee for the Crohn’s and Colitis Foundation, Editorial Board member of the Elsevier Journal Current Research in Immunology. She has also served on multiple NIH Center for Scientific Review Study Sections, and the Nominations committee and Program committee for the American Association of Immunologists.

Dr. Blander has received numerous awards including the 2021 Jeanne and Herbert Siegal Award for Outstanding Medical Research, the 2021 inaugural 2021 X-Seed Award by Deerfield Healthcare Management, a 2019 Sanofi iAward, a 2017 Weill Cornell Medicine Daedalus Award for Innovation, a Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease Award, American Cancer Society Research Scholar Award, Searle Scholar Award, J. V. Satterfield Arthritis Investigator Award, Hirschl and Weill-Caulier Scholar Award, Mount Sinai School of Medicine Faculty Council Junior Faculty Award for Academic Excellence, and the 2009 G. Jeanette Thorbecke Society of Leukocyte Biology award.

Dr. Blander is inventor on six patents. Dr. Blander’s laboratory is funded by the US National Institutes of Health NIAID and NIDDK, Deerfield Healthcare Management, and the Smart Family Foundation.

Prior to joining AIAC, Siobhan worked at Bloomberg LP, UBS Investment Bank, CIBC Oppenheimer and Lehman Brothers.

Siobhan serves as a member of the Board of Directors, Board of Advisors, or Board of Trustees of the following for-profit and non-profit corporations:

Siobhan is an active member of the Association for Corporate Growth, the Turnaround Management Association, and La Asociacon Espanola de Ejecutivas y Consejeras. She is Co-Chairperson of the Harvard Business School Alumni Association and is the Spain and Portugal Chairperson of the International Aviation Women's Association.

Siobhan graduated from Northeastern University in Boston and the Harvard Business School Advanced Management Program.